TY - JOUR
T1 - Human T regulatory cells can use the perforin pathway to cause autologous target cell death
AU - Grossman, William J.
AU - Verbsky, James W.
AU - Barchet, Winfried
AU - Colonna, Marco
AU - Atkinson, John P.
AU - Ley, Timothy J.
N1 - Funding Information:
We thank the Siteman Cancer Center Hi Speed Cell Sorter Core, Haibing Teng for expertise in confocal microscopy, as well as Claudia Kemper, Talal Chatila, John Russell, Andy Bredemeyer, Michael Rettig, and Paula Revell for their support of this work and for comments on the manuscript. This work was supported by grants from the National Institutes of Health (DK 49786 to T.J.L.) (AI37618 to J.P.A.), National Institutes of Health Training Program (NIH 5T32-HD-43010 to J.W.V.), Hope Street Kids Foundation (W.J.G.), and Wisconsin United for Health Foundation (W.J.G.). The license of recombinant murine granzyme B is held by T.J.L. (Sigma). The authors have no other special/competing interests to disclose.
PY - 2004/10
Y1 - 2004/10
N2 - Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill virally infected cells and tumor cells. Mutations in genes important for this pathway are associated with several human diseases. CD4 + T regulatory (Treg) cells have emerged as important in the control of immunopathological processes. We have previously shown that human adaptive Treg cells preferentially express granzyme B and can kill allogeneic target cells in a perforin-dependent manner. Here, we demonstrate that activated human CD4+CD25+ natural Treg cells express granzyme A but very little granzyme B. Furthermore, both Treg subtypes display perforin-dependent cytotoxicity against autologous target cells, including activated CD4 + and CD8+ T cells, CD14+ monocytes, and both immature and mature dendritic cells. This cytotoxicity is dependent on CD18 adhesive interactions but is independent of Fas/FasL. Our findings suggest that the perforin/granzyme pathway is one of the mechanisms that Treg cells can use to control immune responses.
AB - Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill virally infected cells and tumor cells. Mutations in genes important for this pathway are associated with several human diseases. CD4 + T regulatory (Treg) cells have emerged as important in the control of immunopathological processes. We have previously shown that human adaptive Treg cells preferentially express granzyme B and can kill allogeneic target cells in a perforin-dependent manner. Here, we demonstrate that activated human CD4+CD25+ natural Treg cells express granzyme A but very little granzyme B. Furthermore, both Treg subtypes display perforin-dependent cytotoxicity against autologous target cells, including activated CD4 + and CD8+ T cells, CD14+ monocytes, and both immature and mature dendritic cells. This cytotoxicity is dependent on CD18 adhesive interactions but is independent of Fas/FasL. Our findings suggest that the perforin/granzyme pathway is one of the mechanisms that Treg cells can use to control immune responses.
UR - http://www.scopus.com/inward/record.url?scp=5644302161&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2004.09.002
DO - 10.1016/j.immuni.2004.09.002
M3 - Article
C2 - 15485635
AN - SCOPUS:5644302161
SN - 1074-7613
VL - 21
SP - 589
EP - 601
JO - Immunity
JF - Immunity
IS - 4
ER -